Systematic molecular profiling of acute leukemia cancer stem cells allows identification of druggable targets

Acute myeloid leukemia (AML) is one of the most prevalent and acute blood cancers with a poor prognosis and low overall survival rate, especially in the elderly. Although several new AML markers and drug targets have been recently identified, the rate of long-term cancer eradication has not improved...

Descripción completa

Detalles Bibliográficos
Autores principales: Salavaty, Adrian, Shehni, Sara Alaei, Ramialison, Mirana, Currie, Peter D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586918/
https://www.ncbi.nlm.nih.gov/pubmed/36281397
http://dx.doi.org/10.1016/j.heliyon.2022.e11093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586918/
https://www.ncbi.nlm.nih.gov/pubmed/36281397
http://dx.doi.org/10.1016/j.heliyon.2022.e11093

Ejemplares similares